Skip to main content
. 2012 Sep 14;4(6):1321–1324. doi: 10.3892/ol.2012.918

Figure 3.

Figure 3.

Expression levels of miR-544 in serum samples of the validation cohort. The expression levels of miR-544 tended to be lower in anaplastic and glioblastoma patients compared with low-grade gliomas but with no significant difference.